Eva von Schaper. Show Affiliations »
Abstract
Mesh: See more » Biosimilar PharmaceuticalsDrug ApprovalHumansInfliximab/classificationInfliximab/therapeutic useRepublic of KoreaUnited States
Substances: See more » Biosimilar PharmaceuticalsInfliximab
Year: 2016 PMID: 27153263 DOI: 10.1038/nbt0516-454
Source DB: PubMed Journal: Nat Biotechnol ISSN: 1087-0156 Impact factor: 54.908